Year in review

FDA AI medical device clearances in 2018

2018 has 65 AI devices, 140.7% more than 2017 (27). They come from 62 companies. Radiology accounted for 40 (61.5%). The newest decision was AmCAD-UO from AmCad BioMed Corporation on December 28, 2018.

65Decisions in 2018
62Companies
61.5%Share in Radiology
53First-time companies

Decisions by month

Jan: 5Feb: 3Mar: 4Apr: 4May: 6Jun: 6Jul: 4Aug: 3Sep: 3Oct: 5Nov: 10Dec: 12
JanFebMarAprMayJunJulAugSepOctNovDec
FDA AI device decisions by month in 2018: Jan 5, Feb 3, Mar 4, Apr 4, May 6, Jun 6, Jul 4, Aug 3, Sep 3, Oct 5, Nov 10, Dec 12

Pathways

510(k): 58 (89.2%) · De Novo: 7 (10.8%). The first decision in 2018 was WAVE Clinical Platform (January 4, 2018).

Companies with a first AI clearance in 2018

53 companies have their earliest device on this list dated 2018. The busiest of those first-timers is GE Medical Systems Ultrasound and Primary Care Diagnostics, with 2 decisions in 2018. Showing 8 of 53.

Newest decisions in 2018

The full 2018 set is split by specialty above. Radiology in 2018 · Cardiovascular in 2018 · Neurology in 2018

Frequently asked questions

How many AI medical devices did the FDA authorize in 2018?

The FDA list has 65 AI-enabled devices with a final decision dated 2018, from 62 companies.

Which specialty had the most AI clearances in 2018?

Radiology led with 40 devices, 61.5% of 2018.

Which company had the most FDA AI devices in 2018?

Arterys, Inc. had the most, with 2. Next: GE Medical Systems Ultrasound and Primary Care Diagnostics (2), Quantib B.V. (2).

How did 2018 compare with 2017?

2018 has 65 AI devices, 140.7% more than 2017 (27).

How many companies received their first AI-device decision in 2018?

53 companies have their earliest AI-device decision dated 2018.

Cite as: AI Device Radar, “FDA AI medical device clearances in 2018,” https://ai-device-radar.vercel.app/year/2018 (FDA list through 2026-06-29).